Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Stanley Szefler to Biological Availability

This is a "connection" page, showing publications Stanley Szefler has written about Biological Availability.

 
Connection Strength
 
 
 
0.183
 
  1. Kamada AK, Wiener MB, LaVallee NM, Scott MB, Selner JC, Szefler SJ. A pharmacokinetic comparison of two oral liquid glucocorticoid formulations. Pharmacotherapy. 1997 Mar-Apr; 17(2):353-6.
    View in: PubMed
    Score: 0.035
  2. Rogers RJ, Wiener MB, Hill MR, Szefler SJ. Theophylline absorption from two sustained-release products. Implications for therapeutic drug monitoring. Am Rev Respir Dis. 1987 Nov; 136(5):1168-73.
    View in: PubMed
    Score: 0.018
  3. Bartoszek M, Brenner AM, Szefler SJ. Prednisolone and methylprednisolone kinetics in children receiving anticonvulsant therapy. Clin Pharmacol Ther. 1987 Oct; 42(4):424-32.
    View in: PubMed
    Score: 0.018
  4. Haltom JR, Szefler SJ. Theophylline absorption in young asthmatic children receiving sustained-release formulations. J Pediatr. 1985 Nov; 107(5):805-10.
    View in: PubMed
    Score: 0.016
  5. Szefler SJ. Theophylline and its fickle unpredictability of absorption. Ann Allergy. 1985 Oct; 55(4):580-3.
    View in: PubMed
    Score: 0.016
  6. Rogers RJ, Kalisker A, Wiener MB, Szefler SJ. Inconsistent absorption from a sustained-release theophylline preparation during continuous therapy in asthmatic children. J Pediatr. 1985 Mar; 106(3):496-501.
    View in: PubMed
    Score: 0.015
  7. Rohatagi S, Appajosyula S, Derendorf H, Szefler S, Nave R, Zech K, Banerji D. Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective. J Clin Pharmacol. 2004 Jan; 44(1):37-47.
    View in: PubMed
    Score: 0.014
  8. Szefler SJ. Practical considerations in the safe and effective use of theophylline. Pediatr Clin North Am. 1983 Oct; 30(5):943-54.
    View in: PubMed
    Score: 0.014
  9. Szefler SJ. Drug excretion in human breast milk: potential effect on infant development. J Pediatr Gastroenterol Nutr. 1983; 2 Suppl 1:S120-6.
    View in: PubMed
    Score: 0.013
  10. Georgitis JW, Flesher KA, Szefler SJ. Bioavailability assessment of a liquid prednisone preparation. J Allergy Clin Immunol. 1982 Oct; 70(4):243-7.
    View in: PubMed
    Score: 0.013
  11. Dove AM, Szefler SJ, Hill MR, Jusko WJ, Larsen GL, Accurso FJ. Altered prednisolone pharmacokinetics in patients with cystic fibrosis. J Pediatr. 1992 May; 120(5):789-94.
    View in: PubMed
    Score: 0.006
  12. Milsap RL, George DE, Szefler SJ, Murray KA, Lebenthal E, Jusko WJ. Effect of inflammatory bowel disease on absorption and disposition of prednisolone. Dig Dis Sci. 1983 Feb; 28(2):161-8.
    View in: PubMed
    Score: 0.003
  13. Dederich RA, Szefler SJ, Green ER. Intrasubject variation in sustained-release theophylline absorption. J Allergy Clin Immunol. 1981 Jun; 67(6):465-71.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)